English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Using a specific enzyme-linked immunosorbent assay, IL-10 concentrations were measured in serum from 62 patients withulcerative colitis (UC), 43 with Crohn's disease (CD), 25 with other colitides, and 44 normalcontrol subjects. Serum IL-10 concentrations were increased in patients withactive UC but not in those with active CD  when compared with normal control subjects.  A time course studyshowed that in patients with UC and CD, serum concentrations of IL-6 and C-reactive proteinincreased during the acute phase and returned to normal as patients go into remission. Notably,serum IL-10 concentrations increased during the phase of disease resolution and declinedthereafter regardless of the treatment modality. Gel filtration analysis indicated that IL-10circulated predominantly as a dimer. In conclusion, this study shows that serum IL-10 isincreased during disease recovery in patients with inflammatory bowel disease, and may be ahelpful marker in monitoring disease status

Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase